263 related articles for article (PubMed ID: 21714934)
1. Periostin: a promising target of therapeutical intervention for prostate cancer.
Sun C; Zhao X; Xu K; Gong J; Liu W; Ding W; Gou Y; Xia G; Ding Q
J Transl Med; 2011 Jun; 9():99. PubMed ID: 21714934
[TBL] [Abstract][Full Text] [Related]
2. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
[TBL] [Abstract][Full Text] [Related]
3. Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy.
Sun C; Song C; Ma Z; Xu K; Zhang Y; Jin H; Tong S; Ding W; Xia G; Ding Q
Proteome Sci; 2011 Apr; 9():22. PubMed ID: 21504578
[TBL] [Abstract][Full Text] [Related]
4. [Effect of downregulation of prostate cancer antigen-1 expression on malignant biological behavior of prostate cancer LNCaP cells].
Liu BQ; Wang YK; Wu YD; Wei JX; Li X
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):828-32. PubMed ID: 24447480
[TBL] [Abstract][Full Text] [Related]
5. [Silencing ERp29 promotes the invasiveness of human PCa cells in vitro: Molecular mechanisms].
Zhu B; Huang ZC; Deng HH; Dong ZT; Zhao XK; Yang LY; Jiang HY
Zhonghua Nan Ke Xue; 2020 Jul; 26(7):579-587. PubMed ID: 33377711
[TBL] [Abstract][Full Text] [Related]
6. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
8. Dishevelled-2 silencing reduces androgen-dependent prostate tumor cell proliferation and migration and expression of Wnt-3a and matrix metalloproteinases.
Yang Y; Jiao L; Hou J; Xu C; Wang L; Yu Y; Li Y; Yang C; Wang X; Sun Y
Mol Biol Rep; 2013 Jul; 40(7):4241-50. PubMed ID: 23652996
[TBL] [Abstract][Full Text] [Related]
9. The Differential Expression and Function of the Inflammatory Chemokine Receptor CXCR5 in Benign Prostatic Hyperplasia and Prostate Cancer.
Yang L; Gao L; Chen Y; Tang Z; Zhu Y; Han P; Li X; Wei Q
Int J Med Sci; 2015; 12(11):853-61. PubMed ID: 26640404
[TBL] [Abstract][Full Text] [Related]
10. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer.
Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ
J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578
[TBL] [Abstract][Full Text] [Related]
11. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
Guo Z; Liu D; Su Z
Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
[TBL] [Abstract][Full Text] [Related]
12. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
Chen W; Liu Y; Chen H; Ning H; Ding K
Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
[TBL] [Abstract][Full Text] [Related]
13. Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer.
He HJ; Gu XF; Xu WH; Yang DJ; Wang XM; Su Y
Acta Pharmacol Sin; 2013 Feb; 34(2):282-8. PubMed ID: 23023312
[TBL] [Abstract][Full Text] [Related]
14. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.
Liu R; Sun J; Zhang Z; Xu Y
Cell Biol Int; 2012 Oct; 36(10):863-72. PubMed ID: 22612256
[TBL] [Abstract][Full Text] [Related]
15. Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer.
Qiu J; Peng S; Si-Tu J; Hu C; Huang W; Mao Y; Qiu W; Li K; Wang D
BMC Cancer; 2017 May; 17(1):360. PubMed ID: 28532481
[TBL] [Abstract][Full Text] [Related]
16. IgG silencing induces apoptosis and suppresses proliferation, migration and invasion in LNCaP prostate cancer cells.
Xu Y; Chen B; Zheng S; Wen Y; Xu A; Xu K; Li B; Liu C
Cell Mol Biol Lett; 2016; 21():27. PubMed ID: 28536629
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of periostin gene expression via RNA interference suppressed the proliferation, apoptosis and invasion in U2OS cells.
Liu C; Huang SJ; Qin ZL
Chin Med J (Engl); 2010 Dec; 123(24):3677-83. PubMed ID: 22166650
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
19. Silencing of MEOX1 Gene Inhibits Proliferation and Promotes Apoptosis of LNCaP Cells in Prostate Cancer.
Zhu ZY; Wang XL; Li DP
Cancer Biother Radiopharm; 2019 Mar; 34(2):91-102. PubMed ID: 30543460
[TBL] [Abstract][Full Text] [Related]
20. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
[No Abstract] [Full Text] [Related]
[Next] [New Search]